# Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

> **NCT03532854** · PHASE1 · COMPLETED · sponsor: **LG Chem** · enrollment: 42 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Valsartan
- **DRUG:** Ezetimibe/Rosuvastatin

## Key facts

- **NCT ID:** NCT03532854
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-28
- **Primary completion:** 2018-08-25
- **Final completion:** 2019-01-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532854, "Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03532854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*